+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Long-acting Contraception Market - Global Forecast 2025-2030- Product Image
Long-acting Contraception Market - Global Forecast 2025-2030- Product Image
Sale

Long-acting Contraception Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5715566
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Long-acting contraception is becoming increasingly central to preventive health strategies for women and offers consistent, user-friendly solutions that enhance adherence and healthcare efficiency. Senior decision-makers seeking to understand growth dynamics, regulatory shifts, and innovation drivers in this market will find actionable insight in this focused analysis.

Market Snapshot: Long-acting Contraception Market Size & Growth

The Long-acting Contraception Market grew from USD 3.68 billion in 2024 to USD 3.95 billion in 2025. It is expected to continue growing at a CAGR of 6.99%, reaching USD 5.53 billion by 2030. This performance reflects robust global demand and the market’s sustained evolution as healthcare systems and patients shift priorities towards high-efficacy, low-maintenance methods.

Scope & Segmentation: Detailed Market Structure & Technologies

  • Product Type: Includes multi-rod implants, single-rod implants, intramuscular injectables, subcutaneous injectables, copper intrauterine devices (IUDs), and hormonal IUDs.
  • End User: Covers family planning clinics, specialty clinics, private hospitals, and public hospitals—each segment with distinct procurement protocols and clinical workflows.
  • Distribution Channel: Involves hospital pharmacies, online platforms (company websites and third-party portals), chain retail pharmacies, and independent retail pharmacies.
  • Regional Coverage: Analyzes performance trends across the United States (and leading states), Canada, Mexico, Brazil, Argentina, United Kingdom, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland, China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, and Taiwan.
  • Company Analysis: Insights from Bayer AG, Organon & Co., CooperCompanies, AbbVie, Teva Pharmaceutical Industries, Viatris, Mayne Pharma Group, Sun Pharmaceutical Industries, Lupin, and Cipla.

Key Takeaways: Actionable Insights for Senior Stakeholders

  • Expanding patient adoption is driven by advances in implantable devices, injectable formulations, and intrauterine technologies, boosting overall market penetration and care accessibility.
  • Integration of biomaterials and patient-centric designs increasingly enables at-home or low-touch administration, reducing clinical burdens and widening reach among diverse populations.
  • Regulatory agility now underpins accelerated review processes, creating new opportunities for innovative products and fostering stronger collaborations between manufacturers and authorities.
  • Digital health applications such as telemedicine and adherence-tracking apps are supplementing traditional family planning, supporting real-time monitoring and data-informed therapy adjustments.
  • Localized production and supply chain diversification strategies are growing in importance due to external shocks and policy shifts, strengthening healthcare service reliability across key regions.

Tariff Impact: Navigating New Supply Chain and Pricing Challenges

The introduction of revised tariffs in 2025 on US medical components and pharmaceutical intermediates has created substantial pressure throughout the long-acting contraception value chain. Manufacturers relying on affected imports face increased costs, leading to shifts in sourcing, portfolio realignment, and a mix of price adjustments or cost absorption strategies to maintain competitiveness. Industry associations and policymakers are actively engaged in dialogue to advocate for stable trade conditions and reduce future volatility.

Methodology & Data Sources

The report employs a layered methodology, combining in-depth secondary research with targeted primary data collection. Interviews with senior stakeholders, structured surveys, and scenario modeling ensure both qualitative and quantitative rigor, delivering a nuanced and validated market perspective.

Why This Report Matters

  • Enables evidence-based planning for investment, strategic partnerships, and product development in women’s preventive health markets.
  • Delivers granular analysis of regulatory trends, market segmentation, and technology adoption to guide tactical and long-term decision-making.
  • Supports resilient supply chain and pricing strategies in an evolving trade environment, safeguarding sustainable growth potential.

Conclusion

Long-acting contraception is advancing through innovation, policy evolution, and strategic regional expansion. This report equips senior leaders with the clarity and depth required to navigate change and seize emerging market opportunities.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing preference for drug-eluting intrauterine systems with extended efficacy spanning five years and reduced side effects
5.2. Development of biodegradable subcutaneous contraceptive implants providing up to three years of hormone release and simplified removal
5.3. Surge in telemedicine-facilitated IUD insertion services addressing rural and underserved population access gaps
5.4. Innovation in nonhormonal long-acting intrauterine devices using advanced copper alloys and anti-inflammatory surface coatings
5.5. Regulatory approvals for male long-acting reversible contraceptives advancing late-stage trials of on-demand vaso-occlusive gels
5.6. Expansion of postpartum contraceptive implant insertion programs integrated with maternal health initiatives to reduce rapid repeat pregnancies
5.7. Investment surge in implantable microchip technology enabling patient-controlled hormone dosing and remote adherence tracking
5.8. Partnerships between pharmaceutical companies and NGOs to subsidize long-acting contraceptive distribution in low-income regions to boost uptake
5.9. Emphasis on reversible male sterilization with polymer-based intravasal plugs offering six-month efficacy and easy reversibility
5.10. Introduction of extended-duration injectable contraceptives using next-generation progestin formulations with improved metabolic and safety profiles
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Long-acting Contraception Market, by Product Type
8.1. Introduction
8.2. Implant
8.2.1. Multi-Rod Implant
8.2.2. Single-Rod Implant
8.3. Injectable
8.3.1. Intramuscular Injectable
8.3.2. Subcutaneous Injectable
8.4. Intrauterine Device
8.4.1. Copper IUD
8.4.2. Hormonal IUD
9. Long-acting Contraception Market, by End User
9.1. Introduction
9.2. Clinics
9.2.1. Family Planning Clinic
9.2.2. Specialty Clinic
9.3. Hospitals
9.3.1. Private Hospital
9.3.2. Public Hospital
10. Long-acting Contraception Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online
10.3.1. Company Website
10.3.2. Third-Party Platform
10.4. Retail Pharmacy
10.4.1. Chain Pharmacy
10.4.2. Independent Pharmacy
11. Americas Long-acting Contraception Market
11.1. Introduction
11.2. Brazil
11.3. United States
11.4. Mexico
11.5. Canada
11.6. Argentina
12. Europe, Middle East & Africa Long-acting Contraception Market
12.1. Introduction
12.2. United Kingdom
12.3. Nigeria
12.4. France
12.5. Denmark
12.6. Qatar
12.7. Israel
12.8. Italy
12.9. Finland
12.10. Saudi Arabia
12.11. Sweden
12.12. Switzerland
12.13. South Africa
12.14. Poland
12.15. Spain
12.16. Egypt
12.17. Norway
12.18. Turkey
12.19. Netherlands
12.20. Russia
12.21. United Arab Emirates
12.22. Germany
13. Asia-Pacific Long-acting Contraception Market
13.1. Introduction
13.2. China
13.3. South Korea
13.4. Australia
13.5. Thailand
13.6. Indonesia
13.7. Malaysia
13.8. India
13.9. Vietnam
13.10. Taiwan
13.11. Philippines
13.12. Japan
13.13. Singapore
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Bayer AG
14.3.2. Organon & Co.
14.3.3. CooperCompanies, Inc.
14.3.4. AbbVie Inc.
14.3.5. Teva Pharmaceutical Industries Ltd
14.3.6. Viatris Inc
14.3.7. Mayne Pharma Group Limited
14.3.8. Sun Pharmaceutical Industries Ltd
14.3.9. Lupin Limited
14.3.10. Cipla Limited
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. LONG-ACTING CONTRACEPTION MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 12. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 14. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. LONG-ACTING CONTRACEPTION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 20. LONG-ACTING CONTRACEPTION MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 21. LONG-ACTING CONTRACEPTION MARKET: RESEARCHAI
FIGURE 22. LONG-ACTING CONTRACEPTION MARKET: RESEARCHSTATISTICS
FIGURE 23. LONG-ACTING CONTRACEPTION MARKET: RESEARCHCONTACTS
FIGURE 24. LONG-ACTING CONTRACEPTION MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. LONG-ACTING CONTRACEPTION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY MULTI-ROD IMPLANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY MULTI-ROD IMPLANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY SINGLE-ROD IMPLANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY SINGLE-ROD IMPLANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAMUSCULAR INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAMUSCULAR INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY SUBCUTANEOUS INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY SUBCUTANEOUS INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY COPPER IUD, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY COPPER IUD, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY HORMONAL IUD, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY HORMONAL IUD, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY FAMILY PLANNING CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY FAMILY PLANNING CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY COMPANY WEBSITE, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY COMPANY WEBSITE, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY THIRD-PARTY PLATFORM, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY THIRD-PARTY PLATFORM, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 95. BRAZIL LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 96. BRAZIL LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 97. BRAZIL LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2018-2024 (USD MILLION)
TABLE 98. BRAZIL LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2025-2030 (USD MILLION)
TABLE 99. BRAZIL LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 100. BRAZIL LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 101. BRAZIL LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2024 (USD MILLION)
TABLE 102. BRAZIL LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, 2025-2030 (USD MILLION)
TABLE 103. BRAZIL LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. BRAZIL LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. BRAZIL LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 106. BRAZIL LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 107. BRAZIL LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 108. BRAZIL LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 109. BRAZIL LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 110. BRAZIL LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 111. BRAZIL LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 112. BRAZIL LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 137. MEXICO LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 138. MEXICO LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 139. MEXICO LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2018-2024 (USD MILLION)
TABLE 140. MEXICO LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2025-2030 (USD MILLION)
TABLE 141. MEXICO LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 142. MEXICO LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 143. MEXICO LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2024 (USD MILLION)
TABLE 144. MEXICO LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, 2025-2030 (USD MILLION)
TABLE 145. MEXICO LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. MEXICO LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. MEXICO LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 148. MEXICO LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 149. MEXICO LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 150. MEXICO LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 151. MEXICO LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 152. MEXICO LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 153. MEXICO LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 154. MEXICO LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 155. MEXICO LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 156. MEXICO LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 157. CANADA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 158. CANADA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 159. CANADA LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2018-2024 (USD MILLION)
TABLE 160. CANADA LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2025-2030 (USD MILLION)
TABLE 161. CANADA LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 162. CANADA LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 163. CANADA LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2024 (USD MILLION)
TABLE 164. CANADA LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, 2025-2030 (USD MILLION)
TABLE 165. CANADA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. CANADA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. CANADA LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 168. CANADA LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 169. CANADA LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 170. CANADA LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 171. CANADA LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 172. CANADA LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 173. CANADA LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 174. CANADA LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 175. CANADA LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 176. CANADA LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 239. NIGERIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 240. NIGERIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 241. NIGERIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2018-2024 (USD MILLION)
TABLE 242. NIGERIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2025-2030 (USD MILLION)
TABLE 243. NIGERIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 244. NIGERIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 245. NIGERIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2024 (USD MILLION)
TABLE 246. NIGERIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, 2025-2030 (USD MILLION)
TABLE 247. NIGERIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. NIGERIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. NIGERIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 250. NIGERIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 251. NIGERIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 252. NIGERIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 253. NIGERIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. NIGERIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. NIGERIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 256. NIGERIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 257. NIGERIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 258. NIGERIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 259. FRANCE LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 260. FRANCE LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 261. FRANCE LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2018-2024 (USD MILLION)
TABLE 262. FRANCE LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2025-2030 (USD MILLION)
TABLE 263. FRANCE LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 264. FRANCE LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 265. FRANCE LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2024 (USD MILLION)
TABLE 266. FRANCE LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, 2025-2030 (USD MILLION)
TABLE 267. FRANCE LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. FRANCE LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. FRANCE LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 270. FRANCE LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 271. FRANCE LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 272. FRANCE LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 273. FRANCE LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 274. FRANCE LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 275. FRANCE LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 276. FRANCE LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 277. FRANCE LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 278. FRANCE LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 279. DENMARK LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 280. DENMARK LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 281. DENMARK LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2018-2024 (USD MILLION)
TABLE 282. DENMARK LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2025-2030 (USD MILLION)
TABLE 283. DENMARK LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 284. DENMARK LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 285. DENMARK LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2024 (USD MILLION)
TABLE 286. DENMARK LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, 2025-2030 (USD MILLION)
TABLE 287. DENMARK LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 288. DENMARK LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 289. DENMARK LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 290. DENMARK LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 291. DENMARK LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 292. DENMARK LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 293. DENMARK LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 294. DENMARK LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 295. DENMARK LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 296. DENMARK LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 297. DENMARK LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 298. DENMARK LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 299. QATAR LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 300. QATAR LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 301. QATAR LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2018-2024 (USD MILLION)
TABLE 302. QATAR LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2025-2030 (USD MILLION)
TABLE 303. QATAR LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 304. QATAR LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 305. QATAR LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2024 (USD MILLION)
TABLE 306. QATAR LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICE, 2025-2030 (USD MILLION)
TABLE 307. QATAR LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 308. QATAR LONG-ACTING CONTRACEPTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 309. QATAR LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 310. QATAR LONG-ACTING CONTRACEPTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 311. QATAR LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 312. QATAR LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 313. QATAR LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 314. QATAR LONG-ACTING CONTRACEPTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 315. QATAR LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 316. QATAR LONG-ACTING CONTRACEPTION MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 317. QATAR LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 318. QATAR LONG-ACTING CONTRACEPTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 319. ISRAEL LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 320. ISRAEL LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 321. ISRAEL LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2018-2024 (USD MILLION)
TABLE 322. ISRAEL LONG-ACTING CONTRACEPTION MARKET SIZE, BY IMPLANT, 2025-2030 (USD MILLION)
TABLE 323. ISRAEL LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 324. ISRAEL LONG-ACTING CO

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Long-acting Contraception market report include:
  • Bayer AG
  • Organon & Co.
  • CooperCompanies, Inc.
  • AbbVie Inc.
  • Teva Pharmaceutical Industries Ltd
  • Viatris Inc
  • Mayne Pharma Group Limited
  • Sun Pharmaceutical Industries Ltd
  • Lupin Limited
  • Cipla Limited

Table Information

Report AttributeDetails
No. of Pages190
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.95 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.53 Billion
Compound Annual Growth Rate6.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Contraception Manufacturers - Industry Report - Product Image

Contraception Manufacturers - Industry Report

  • Report
  • 121 Pages
  • Global
From
Contraceptive Drugs And Devices Global Market Report 2025 - Product Image

Contraceptive Drugs And Devices Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Women's Health Market Size, Share & Trends Analysis Report By Application (Contraceptives, Menopause), By Drug Class (Hormonal Therapies, Pain And Symptom Management), By Age (50 Years And Above), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Women's Health Market Size, Share & Trends Analysis Report By Application (Contraceptives, Menopause), By Drug Class (Hormonal Therapies, Pain And Symptom Management), By Age (50 Years And Above), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 130 Pages
  • Global
From
Contraceptive Devices Market Report 2025 - Product Image

Contraceptive Devices Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Contraceptive Device Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Contraceptive Device Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 89 Pages
  • Global
From

About the Long Acting Contraception Market

The Long Acting Contraception market is a subset of the Personal Care Products industry. It includes a variety of products designed to provide long-term contraception, such as intrauterine devices (IUDs), contraceptive implants, and injectable contraceptives. These products are designed to provide a safe and effective form of contraception for women who wish to avoid pregnancy. Long Acting Contraception products are typically used by women who are looking for a more reliable form of contraception than traditional methods, such as the pill or condoms. They are also used by women who are looking for a more convenient form of contraception, as they do not require daily or weekly use. The Long Acting Contraception market is highly competitive, with a number of companies offering products. Some of the major players in the market include Bayer, Merck, Allergan, and Teva Pharmaceuticals. These companies offer a variety of products, ranging from IUDs to contraceptive implants and injectable contraceptives. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.